Jonas Grossman - Mar 9, 2023 Form 4 Insider Report for Monterey Innovation Acquisition Corp (MTRY)

Role
Director, 10%+ Owner
Signature
/s/ Jason T. Simon, as Attorney-in-Fact
Stock symbol
MTRY
Transactions as of
Mar 9, 2023
Transactions value $
$2,790
Form type
4
Date filed
3/13/2023, 09:57 PM
Previous filing
Dec 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTRY Common Stock Sale -$79 -13.1K -2.06% $0.01* 624K Mar 9, 2023 By Chardan Monterey Investments LLC F1, F2
transaction MTRY Common Stock Purchase $2.87K +478K +76.58% $0.01* 1.1M Mar 9, 2023 By Chardan Monterey Investments LLC F2, F3
holding MTRY Common Stock 35K Mar 9, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock transferred from Chardan Monterey Investments LLC ("Chardan") to certain affiliates of Chardan for a price per share of $0.006, pursuant to Share Transfer Agreements dated March 9, 2023.
F2 The shares are held directly by Chardan. The Reporting Person is the managing member of Chardan. Accordingly, the Reporting Person has voting and dispositive power over the shares held by Chardan and may be deemed to beneficially own such shares. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F3 Represents shares of common stock transferred from NorthStar Bio Ventures, LLC ("NorthStar") to Chardan for a price per share of $0.006, pursuant to a Share Transfer Agreement dated March 9, 2023.